行情

NMRD

NMRD

NEMAURA MEDICAL
NASDAQ

实时行情|Nasdaq Last Sale

2.911
+0.061
+2.14%
已收盘, 16:00 01/28 EST
开盘
2.870
昨收
2.850
最高
2.911
最低
2.760
成交量
5,380
成交额
--
52周最高
19.30
52周最低
2.500
市值
6,056.98万
市盈率(TTM)
-1.2262
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

NMRD 新闻

  • 苹果假期季度业绩强于预估 受iPhone需求强劲提振
  • 新浪财经.2小时前
  • 南非亿万富翁说非洲人爱特朗普 被痛批后道歉
  • 新浪财经.3小时前
  • 日产在美销量大减 将向当地老员工提供工龄买断计划
  • 新浪财经.4小时前
  • 澳大利亚科学家成功培育出新型冠状病毒样本
  • 中国新闻网.4小时前

更多

所属板块

医疗设备、用品及经销
+0.33%
医疗设备和用品
+0.58%

热门股票

名称
价格
涨跌幅

NMRD 简况

Nemaura Medical, Inc. is a holding company. The Company owns a diagnostic medical device company specializing in discovering, developing and commercializing specialty medical devices. The Company's focus is on the development of a continuous glucose monitoring (CGM) device, which consists of a disposable patch containing a sensor, and a non-disposable miniature electronic watch with a re-chargeable power source. CGM through a non-invasive patch can enable early detection of subtle changes in blood glucose levels. The Company, through its operating subsidiaries, performs medical device research and manufacturing of a CGM, named sugarBEAT. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes, and may also be used to screen pre-diabetic patients. The sugarBEAT device extracts analytes, such as glucose, to the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm.
展开

Webull提供Nemaura Medical Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。